Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2026-08-18 17:03:32 ET · period of report 2026-08-14 · accession 0001773751-26-000205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:03 | 2026-08-14 | HIMS | Payne Christopher D | Dir | M - OptEx | — | +545 | 34.9K | +2% | — |
| D | 2026-08-18 17:03 | 2026-08-14 | HIMS | Payne Christopher D | Dir | M - OptEx | $0.00 | -545 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-08-14 | M | A | 545 | — | 34,863 | D | — | — | (F1) The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |
| 2 | Derivative | Restricted Stock Unit | 2026-08-14 | M | D | 545 | $0.00 | 0 | D | — · — to — | 545 Class A Common Stock | (F1) The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. (F1) The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. (F1) The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. |